Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu

Curaleaf stocks up 3.3% after announcing deal with CVS

Z-ARCHIVE-Cannabis Patent Forecast®

March 22, 2019

CVS and Curaleaf have struck a deal that allows Curaleaf to sell their CBD products at select CVS locations around the US. CVS currently sells CBD products in 8 states including Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee. Curaleaf stocks rose 3.3% with the announcement of the deal. 


Article Source Link

www.marketwatch.com


View Patent Forecast®

Cannabis is now legally being used to treat a wide variety of medical conditions, including chronic pain, alcoholism, anxiety, nausea (from chemotherapy) and epilepsy.

Z-ARCHIVE-Cannabis   Patent Forecast®

View Patent Forecast® Top Corporations News and Insights Data Visualization

Cannabis is now legally being used to treat a wide variety of medical conditions, including chronic pain, alcoholism, anxiety, nausea (from chemotherapy) and epilepsy.



301